BEVERLY PENNINGTON
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family GALVESTON, TX NPI 1558728014
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family TX Janssen Pharmaceuticals, Inc All categories
General Payments — all program years on this page
$1,273.41
- Category: General Payments
- Program years: PY2021–2024
- Record count: 22
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $466.56 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $466.56 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $210.18 | 1 |
| Inspire Medical Systems, Inc. | $110.36 | 1 |
| Lilly USA, LLC | $50.85 | 3 |
| ABIOMED | $39.31 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $34.98 | 1 |
| Novo Nordisk AS | $20.88 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078201941 | Janssen Pharmaceuticals, Inc | $210.18 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1087340311 | Novartis Pharmaceuticals Corporation | $34.98 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100225900 | Novo Nordisk Inc | $20.88 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135541278 | Lilly USA, LLC | $16.83 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135586319 | Lilly USA, LLC | $17.45 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135601771 | Lilly USA, LLC | $16.57 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142306383 | ABIOMED | $39.31 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148165380 | Inspire Medical Systems, Inc. | $110.36 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.